Works matching IS 00282685 AND DT 2025 AND VI 72 AND IP 1/2

Results: 14

Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 144, doi. 10.4149/neo_2025_250319N130

By:

Wen WANG;
Baoxiang LUO;
Zhengjun WANG;
Ji ZHANG;
Zhou YE;
Xiaojian HE;
Dazhou LI;
Dongjie SUN

Publication type:

Article

Elevated expression of HSF1 promotes the progression of colorectal cancer by activating CLDN3 transcription.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 67, doi. 10.4149/neo_2025_241031N442

By:

Yanxi SHAO;
Ting MA;
Dening MA;
Lue HONG;
Min LV;
Shiqi ZHOU;
Zhibin FANG;
Enyan YU;
Xia LI;
Yuping ZHU

Publication type:

Article

Clinical experience and safety of venetoclax in the treatment of patients with chronic lymphocytic leukemia -- real-world data from a hemato-oncology center.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 137, doi. 10.4149/neo_2025_241211N518

By:

HOLASOVÁ, Juliana;
WILD, Alexander;
HRUBIŠKO, Mikuláš

Publication type:

Article

EIF4E promotes gefitinib resistance in non-small cell lung cancer by activating the Wnt/β-catenin pathway.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 118, doi. 10.4149/neo_2025_250113N19

By:

Bo ZHANG;
Jiani ZHU;
Zixian JIN;
Jiawei LIANG;
Ziming WANG;
Quanteng HU;
Lilong XIA

Publication type:

Article

CCL18 derived from M2-polarized tumor-associated macrophages promotes endometrial cancer progression by activating the TWIST1/HMGA1 axis.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 106, doi. 10.4149/neo_2025_240820N357

By:

Hongxia LI;
Jiansheng LI

Publication type:

Article

IL4I1 knockdown inhibits the epithelial-mesenchymal transition process in glioma via downregulation of the JAK2/STAT3 signaling pathway.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 91, doi. 10.4149/neo_2025_250110N13

By:

Jianwei ZHUO;
Tong WANG;
Ting LU;
Xiangying LI;
Zhengquan YU;
Gang CUI;
Haitao SHEN

Publication type:

Article

KLHL7 enhances cell viability and cell cycle progression in glioma via glutamine metabolism by activating the β-catenin signaling pathway.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 80, doi. 10.4149/neo_2025_241227N539

By:

Rui LIU;
Xiaoju CHENG;
Peirui WANG;
Xiangping XIA;
Gang LI;
Fuan ZHANG;
Chong HAN;
Shengtao YAO

Publication type:

Article

Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancer.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 128, doi. 10.4149/neo_2025_241021N429

By:

Beibei CHEN;
Huichen ZHAO;
Huihui HU;
Jinxi HUANG;
Yingjun LIU;
Huifang LV;
Weifeng XU;
Jianzheng WANG;
Caiyun NIE;
Jing ZHAO;
Yunduan HE;
Saiqi WANG;
Yuhang WANG;
Xiaobing CHEN

Publication type:

Article

EGFR/STAT3 signaling mediates the upregulation of CD47 in HPV-positive cervical cancer by activating p65 and exosome transporter RAB31.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 59, doi. 10.4149/neo_2025_241017N421

By:

Xiaoping KE;
Li LI;
Qi YAN;
Xianjing WANG;
Ping LIU

Publication type:

Article

20(S)-ginsenoside Rg3 induced the necroptosis of prostate cancer cells via ROS overproduction.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 48, doi. 10.4149/neo_2025_240925N402

By:

Yanfei PENG;
Yaping GUO;
Shuwu ZHAO;
Hao YAN;
Zheng HAO;
Fang ZHENG;
Zhaiyi ZHANG;
Lin MIAO;
Li-kang SUN;
CUENDET, Muriel

Publication type:

Article

Triptonide inhibits the progression of oral squamous cell carcinoma by suppressing the TRIP13/c-Myc axis.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 36, doi. 10.4149/neo_2025_240918N387

By:

Hongbo ZHANG;
Zheng WEI;
Shengwei HAN;
Sufeng ZHAO

Publication type:

Article

Nuclear factor I-C aggravates acute myelogenous leukemia by inhibiting SRY-box transcription factor 1 to activate autophagy.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 25, doi. 10.4149/neo_2025_240905N376

By:

Cong LUO;
Zeyu LUO;
Junjun LI;
Feng WEN;
Yixiong CAO;
Qiong LIU;
Xingxing LONG

Publication type:

Article

Inhibition of enzymatic activity of HRD1 results in death of cells derived from glioblastoma multiforme, neuroblastoma, and normal astrocytes.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 16, doi. 10.4149/neo_2025_241120N481

By:

GUZIKOVA, Jaroslava;
LISKOVA, Monika;
HUDAK, Lubos;
BRODNANOVA, Maria;
EVINOVA, Andrea;
HATOK, Jozef;
RACAY, Peter

Publication type:

Article

Research progress on the regulation mechanism of DEPTOR expression and its role in tumorigenesis.

Published in:

Neoplasma, 2025, v. 72, n. 1/2, p. 1, doi. 10.4149/neo_2025_241203N504

By:

Jinni JIANG;
Chengyu ZHAO;
Minglei YANG;
Guofang ZHAO;
Jianfeng SHU

Publication type:

Article